Quarterly report [Sections 13 or 15(d)]

Statements of Cash Flows (Unaudited)

v3.26.3
Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:              
Net loss $ (2,821,400) $ (1,847,706) $ (1,691,989) $ (2,303,587) $ (7,636,169) $ (5,696,669)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation and amortization         12,911  
Stock-based compensation 42,179   37,840   127,237 114,263  
Increase (decrease) in cash resulting from changes in:              
Prepaid expenses and other current assets         (243,384) (34,965)  
Inventories         (825,279)  
Other assets         (45,637)  
Accounts payable         1,175,127 (304,089)  
Accrued and other current liabilities         (115,829) (506,902)  
Net cash used in operating activities         (7,551,023) (6,428,362) $ (7,800,000)
Cash flows from investing activities:              
Purchases of property and equipment         (163,647)  
Net cash used in investing activities         (163,647)  
Cash flows from financing activities:              
Proceeds from issuance of Common Stock from ATM sales, net of issuance costs         1,994,051  
Proceeds from issuance of Common Stock, pre-funded warrants, and warrants, net of issuance costs         3,312,350 7,980,804  
Proceeds from exercise of pre-funded warrants         977  
Payment of issuance costs         (91,352) (50,495)  
Payment for fractional shares in reverse stock split         (367)  
Net cash provided by financing activities         5,215,049 7,930,919  
Net increase (decrease) in cash and cash equivalents         (2,499,621) 1,502,557  
Cash, cash equivalents and restricted cash at beginning of period   $ 7,521,978   $ 3,161,570 7,521,978 3,161,570 3,161,570
Total cash, cash equivalents and restricted cash 5,022,357   4,664,127   5,022,357 4,664,127 7,521,978
Reconciliation of cash, cash equivalents and restricted cash to the balance sheets              
Cash and cash equivalents 4,822,357   4,664,127   4,822,357 4,664,127 $ 7,521,978
Restricted cash $ 200,000     200,000  
Non-cash investing and financing activities:              
Issuance of Common Stock upon exercise of pre-funded warrants         54  
Purchases of property and equipment included in accounts payable         6,250  
Issuance of abeyance shares         (24)  
Issuance costs in accounts payable and accrued expenses         114,923  
Supplemental disclosure:              
Cash paid for taxes         $ 950 $ 950